期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Oncologie LetPub Score 4.9
50 ratings
Rate
Reputation 6.4 Influence 3.3 Speed 7.0 | ||||||||||||||||
期刊簡稱 | ONCOLOGIE | ||||||||||||||||
ISSN | 1292-3818 | ||||||||||||||||
E-ISSN | 1765-2839 | ||||||||||||||||
h-index | 9 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 7.10%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.techscience.com/journal/oncologie | ||||||||||||||||
在線稿件提交 | http://www.tspsubmission.com/index.php/oncologie/about/submissions | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Tech Science Press | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | FRANCE | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 2004 | ||||||||||||||||
每年文章數 | 78每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 78.57% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1292-3818%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[Oncologie] 的評論 | 撰寫評論 |
作者: 上清彭勃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-27 18:38:02 評論於 Me too, same question.(0) 讚! | 上清彭勃 |
作者: 上清明喆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-02 23:02:16 評論於 How much is the layout fee?(0) 讚! | 上清明喆 |
作者: 墟散剑博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-27 16:27:45 評論於 How do you format citations for references?(0) 讚! | 墟散剑博 |
作者: 黄土佳沫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-05 14:16:37 評論於 Should I submit in PDF format or LaTeX format?(0) 讚! | 黄土佳沫 |
作者: doctor su 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-22 17:11:46 評論於 Overall, this magazine is pretty good, but there is a high percentage of Chinese authors, which could have potential risks(0) 讚! | doctor su |
作者: doctor su 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-22 17:09:05 評論於 Overall, this magazine is pretty good, but the proportion of Chinese authors is too high. I wonder if there is a risk of lack of diversity(0) 讚! | doctor su |
作者: doctor su 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-22 17:07:49 評論於 This magazine looks good. The impact factor should exceed 1 this year, but I feel there is a risk. Not sure if the high proportion of Chinese authors will trigger a warning(0) 讚! | doctor su |
作者: 东海梦雁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-12 17:33:25 評論於 Review speed: 1.0 | Acceptance rate: 75.0 Experience sharing: The journal review speed is quite fast, and it was accepted in a little over a month. The reviewers' comments were very professional. Hopefully, the impact factor will increase again(0) 讚! | 东海梦雁 |
作者: 通幽其倩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-27 17:24:25 評論於 Desperately seeking EndNote format! Or which format is easier to modify?(0) 讚! | 通幽其倩 |
作者: 杨家梦森 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-06 21:26:51 評論於 You(0) 讚! | 杨家梦森 |
作者: 白云向阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-27 21:20:16 評論於 At that time, we were still using the old system, there was no specific review status, and we received a revised email a month later(0) 讚! | 白云向阳 |
作者: 白云向阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-27 15:28:09 評論於 There is no specific format for Endnote, so I had to adjust them one by one based on a similar one I found(0) 讚! | 白云向阳 |
作者: 岭南雅柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-06 21:45:58 評論於 Hello, what is the specific reference format? I couldn't find the same in Endnote(0) 讚! | 岭南雅柔 |
作者: 岭南雅柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-06 10:26:48 評論於 What is the format of the reference list? I couldn't find the document package on the official website ?(0) 讚! | 岭南雅柔 |
作者: 岭南雅柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-06 10:19:48 評論於 Hello, what format is the specific reference in? I can't find this journal in Endnote(0) 讚! | 岭南雅柔 |
作者: 岭南睿聪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-30 13:23:58 評論於 When is the first decision going to be made? Will the external review have a clear status?(0) 讚! | 岭南睿聪 |
作者: Julia Coverdale 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-28 21:09:08 評論於 How can I find the submission guidelines for a magazine?(0) 讚! | Julia Coverdale |
作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-28 20:42:24 評論於 The submission information in the left menu contains a homepage(0) 讚! | 是志丹吖 |
作者: Julia Coverdale 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-28 14:52:39 評論於 How can I find the magazine's homepage?(0) 讚! | Julia Coverdale |
作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-28 12:59:39 評論於 The homepage is in the submission information on the left menu(0) 讚! | 是志丹吖 |
作者: 金山清馨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-28 08:41:06 評論於 May I ask at which stage the status "Under Review" is currently? Is it undergoing internal review or external review?(0) 讚! | 金山清馨 |
作者: 岭南睿聪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-27 22:54:03 評論於 How can I register an account?(0) 讚! | 岭南睿聪 |
作者: Eric Marshall 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-01 21:27:52 評論於 Review Speed: 1.0 Experience Sharing: 2(0) 讚! | Eric Marshall |
作者: 白云向阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-16 13:00:59 評論於 Review Speed: 1.0 | Submission Hit Rate: 95.0 Research Focus: Tumor Experience Sharing: 22.10.31 submitted, received review comments on 11.30, minor revisions, given two weeks to revise, editor was very good, can apply for more time if feel it's not enough. Returned for revisions on 12.20, accepted on 12.29. Paid a publication fee of one thousand euros on 2023.1.3, online on 2.14, indexed on 4.6. Overall, it was still very fast, although it's a fourth-tier journal, the impact factor is not high, but it solved the problem of graduating(0) 讚! | 白云向阳 |
作者: 火焰俊豪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-13 21:43:32 評論於 Please translate the following passage into English and Japanese, and use ":" and ":" as headings(0) 讚! | 火焰俊豪 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us